Generate Biomedicines
Clinical trials sponsored by Generate Biomedicines, explained in plain language.
-
New asthma and COPD drug enters first human safety tests
Symptom relief OngoingThis early-stage study tests a new medicine called GB-0895 in adults with mild-to-moderate asthma or COPD. The main goal is to check if the drug is safe and how the body handles it. About 156 participants will receive either the drug or a placebo. This research is a first step to…
Phase: PHASE1 • Sponsor: Generate Biomedicines • Aim: Symptom relief
Last updated May 26, 2026 05:29 UTC
-
New eczema drug candidate tested in healthy people for first time
Knowledge-focused OngoingThis early-stage study tests a new medicine called GB-7624 in 40 healthy adults to see if it is safe and how the body processes it. The study has two parts: one group gets a single dose, and another gets two doses over two weeks. This research is a first step toward possibly trea…
Phase: PHASE1 • Sponsor: Generate Biomedicines • Aim: Knowledge-focused
Last updated May 18, 2026 12:00 UTC